Concepedia

Hong Qin

HQ

Statistics

Publications

37

Citations

2.5K

H-Index

24

Active since

1996

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Beijing Children’s Hospital

Mayo Clinic in Florida

Capital Medical University

The University of Texas at Austin

Hong Qin is an author at The University of Texas MD Anderson Cancer Center specializing in immunology, oncology, and cancer immunology.

ORCID

Publications per year

1996–2025

37

Publications

37

Phase I Escalating-Dose Trial of CAR-T Therapy Targeting CEA+ Metastatic Colorectal Cancers

Chengcheng Zhang, Zhe Wang, Zhi Yang et al. · Molecular Therapy · 2017 · 444 citations · Full text

, , +17

Plasmacytoid dendritic cells induce NK cell–dependent, tumor antigen–specific T cell cross-priming and tumor regression in mice

Chengwen Liu, Yanyan Lou, Gregory Lizée et al. · Journal of Clinical Investigation · 2008 · 303 citations · Full text

, , +17

Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice

Hong Qin, Beatrisa Lerman, Ippei Sakamaki et al. · Nature Medicine · 2014 · 235 citations · Full text

, , +15

Identification of a gag-encoded cytotoxic T-lymphocyte epitope from FBL-3 leukemia shared by Friend, Moloney, and Rauscher murine leukemia virus-induced tumors

W Chen, Hong Qin, Bruce Chesebro et al. · Journal of Virology · 1996 · 137 citations · Full text

, , +17

CAR T cells targeting BAFF-R can overcome CD19 antigen loss in B cell malignancies

Hong Qin, Zhenyuan Dong, Xiuli Wang et al. · Science Translational Medicine · 2019 · 102 citations · Full text

, , +16

1–5 of 37